Unbiased analysis by high throughput sequencing of the viral diversity in fetal bovine serum and trypsin used in cell culture

Biologicals

Volumn 42, Issue 3, 2014, Pages 145-152

  Gagnieur, Léa ^a   Cheval, Justine ^b   Gratigny, Marlène ^b   Hébert, Charles ^b   Muth, Erika ^b   Dumarest, Marine ^a   Eloit, Marc ^a,b,c  

^a INSTITUT PASTEUR   (France)

^b PathoQuest   (France)

^c ECOLE NATIONALE VÉTÉRINAIRE D ALFORT   (France)

Author keywords

Fetal bovine serum; High throughput sequencing; Parvovirus; Pegivirus; Trypsin; Virus

Indexed keywords

CONTIG; FETAL BOVINE SERUM; REAGENT; TRYPSIN; UNCLASSIFIED DRUG;

5' UNTRANSLATED REGION; ARTICLE; BIOINFORMATICS; BOCAVIRUS; BOVINE PARVOVIRUS 3; BOVINE VIRAL DIARRHEA VIRUS 1; BOVINE VIRAL DIARRHEA VIRUS 2; BOVINE VIRAL DIARRHEA VIRUS 3; CELL CULTURE; CIRCOVIRUS; COMPARATIVE STUDY; CONTROLLED STUDY; HIGH THROUGHPUT SEQUENCING; NONHUMAN; NUCLEIC ACID DATABASE; NUCLEOTIDE SEQUENCE; PESTIVIRUS; POLYMERASE CHAIN REACTION; PORCINE CIRCOVIRUS TYPE 2; PRIORITY JOURNAL; PROTEIN DATABASE; QUALITY CONTROL; SEQUENCE ANALYSIS; SPECIES DIVERSITY; TAXONOMY; VALIDATION PROCESS; VIRAL DIVERSITY; VIRAL PHENOMENA AND FUNCTIONS; VIRUS IDENTIFICATION; VIRUS LOAD; VIRUS STRAIN; ANIMAL; BOVINAE; BOVINE DIARRHEA VIRUS; CLASSIFICATION; GENETICS; POLYOMA VIRUS; PROCEDURES;

BOVINAE; BOVINE PARVOVIRUS; BOVINE PARVOVIRUS TYPE 3; BOVINE VIRAL DIARRHEA VIRUS 1; PARVOVIRUS; PORCINE CIRCOVIRUS 2;

ANIMALS; CATTLE; CELLS, CULTURED; DIARRHEA VIRUSES, BOVINE VIRAL; HIGH-THROUGHPUT NUCLEOTIDE SEQUENCING; POLYMERASE CHAIN REACTION; POLYOMAVIRUS;

EID: 84901009849     PISSN: 10451056     EISSN: 10958320     Source Type: Journal    
DOI: 10.1016/j.biologicals.2014.02.002     Document Type: Article

References (45)

1. Campbell G.L., Mataczynski J.D., Reisdorf E.S., Powell J.W., Martin D.A., Lambert A.J., et al. Second human case of cache Valley virus disease. Emerg Infect Dis 2006, 12:854-856.
2. Bethencourt V. Virus stalls Genzyme plant. Nat Biotech 2009, 27:681-682.
3. Nims R.W. Detection of adventitious viruses in biologicals-a rare occurrence. Dev Biol (Basel) 2006, 123:153-164. [discussion 183-97].
4. Victoria J.G., Wang C., Jones M.S., Jaing C., Mcloughlin K., Gardner S., et al. Viral nucleic acids in live-attenuated vaccines: detection of minority variants and an adventitious virus. J Virol 2010, 84:6033-6040.
5. 9 CFR - Code of Federal Regulations -113.53-Requirements for ingredients of animal origin used for production of biologics, (n.d.).
6. EMA/CHMP/BWP/457920/2012 rev 1 Committee for Medicinal Products for Human Use (CHMP) Guideline on the use of bovine serum in the manufacture of human biological medicinal products, (n.d.).
7. Karesh W.B., Dobson A., Lloyd-Smith J.O., Lubroth J., Dixon M.A., Bennett M., et al. Ecology of zoonoses: natural and unnatural histories. Lancet 2012, 380:1936-1945.
8. Mokili J.L., Rohwer F., Dutilh B.E. Metagenomics and future perspectives in virus discovery. Curr Opin Virol 2012, 2:63-77.
9. Berthet N., Leclercq I., Dublineau A., Shigematsu S., Burguière A.M., Filippone C., et al. High-density resequencing DNA microarrays in public health emergencies. Nat Biotechnol 2010, 28:25-27.
10. Chen E.C., Miller S.A., Derisi J.L., Chiu C.Y. Using a pan-viral microarray assay (Virochip) to screen clinical samples for viral pathogens. J Vis Exp 2011, 50:2536-2539.
11. Chang Y., Cesarman E., Pessin M.S., Lee F., Culpepper J., Knowles D.M., et al. Identification of herpesvirus-like DNA sequences in AIDS-associated Kaposi's sarcoma. Science 1994, 266:1865-1869.
12. Birkenmeyer L.G., Desai S.M., Muerhoff A.S., Leary T.P., Simons J.N., Montes C.C., et al. Isolation of a GB virus-related genome from a chimpanzee. J Med Virol 1998, 56:44-51.
13. Nishizawa T., Okamoto H., Konishi K., Yoshizawa H., Miyakawa Y., Mayumi M. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys Res Commun 1997, 241:92-97.
14. Allander T., Tammi M.T., Eriksson M., Bjerkner A., Tiveljung-Lindell A., Andersson B. Cloning of a human parvovirus by molecular screening of respiratory tract samples. Proc Natl Acad Sci USA 2005, 102:12891-12896.
15. Simons J.N., Pilot-Matias T.J., Leary T.P., Dawson G.J., Desai S.M., Schlauder G.G., et al. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc Natl Acad Sci USA 1995, 92:3401-3405.
16. Allander T., Emerson S.U., Engle R.E., Purcell R.H., Bukh J. A virus discovery method incorporating DNase treatment and its application to the identification of two bovine parvovirus species. Proc Natl Acad Sci USA 2001, 98:11609-11614.
17. Greninger A.L., Chen E.C., Sittler T., Scheinerman A., Roubinian N., Yu G., et al. A metagenomic analysis of pandemic influenza A (2009 H1N1) infection in patients from North America. PLoS ONE 2010, 5:e13381.
18. Capobianchi M.R., Giombini E., Rozera G. Next-generation sequencing technology in clinical virology. Clin Microbiol Infect 2013, 19:15-22.
19. Sauvage V., Foulongne V., Cheval J., Ar Gouilh M., Pariente K., Dereure O., et al. Human polyomavirus related to African green monkey lymphotropic polyomavirus. Emerg Infect Dis 2011, 17:1364-1370.
20. Sauvage V., Cheval J., Foulongne V., Gouilh M.A., Pariente K., Manuguerra J.C., et al. Identification of the first human gyrovirus, a virus related to chicken anemia virus. J Virol 2011, 85:7948-7950.
21. Sauvage V., Ar Gouilh M., Cheval J., Muth E., Pariente K., Burguiere A., et al. A member of a new Picornaviridae genus is Shed in pig Feces. J Virol 2012, 86:10036-10046.
22. Cheval J., Sauvage V., Frangeul L., Dacheux L., Guigon G., Dumey N., et al. Evaluation of high-throughput sequencing for identifying known and unknown viruses in biological samples. J Clin Microbiol 2011, 49:3268-3275.
23. Dereure O., Cheval J., Du Thanh A., Pariente K., Sauvage V., Claude Manuguerra J., et al. No evidence for viral sequences in mycosis fungoides and Sézary syndrome skin lesions: a high-throughput sequencing approach. J Invest Dermatol 2013, 133:853-855.
24. Naccache S.N., Greninger A.L., Lee D., Coffey L.L., Phan T., Rein-Weston A., et al. The perils of pathogen discovery: origin of a novel parvovirus-like hybrid genome traced to nucleic acid extraction spin columns. J Virol 2013, 87:11966-11977.
25. Smuts H., Kew M., Khan A., Korsman S. Novel hybrid parvovirus-like virus, NIH-CQV/PHV, contaminants in silica column-based nucleic acid extraction kits. J Virol 2014, 88:1398.
26. Ridpath J.F., Bolin S.R. Differentiation of types 1a, 1b and 2 bovine viral diarrhoea virus (BVDV) by PCR. Mol Cell Probes 1998, 12:101-106.
27. Pinheiro de Oliveira T.F., Fonseca A.A., Camargos M.F., de Oliveira A.M., Pinto Cottorello A.C., Souza A.D.R., et al. Detection of contaminants in cell cultures, sera and trypsin. Biologicals 2013, 41(6):407-414.
28. Liu L., Xia H., Belák S., Baule C. A TaqMan real-time RT-PCR assay for selective detection of atypical bovine pestiviruses in clinical samples and biological products. J Virol Methods 2008, 154:82-85.
29. Xiao C.-T., Giménez-Lirola L.G., Jiang Y.-H., Halbur P.G., Opriessnig T. Characterization of a novel porcine parvovirus tentatively designated PPV5. PLoS ONE 2013, 8:e65312.
30. Kapoor A., Simmonds P., Cullen J.M., Scheel T.K.H., Medina J.L., Giannitti F., et al. Identification of a pegivirus (GB virus-like virus) that infects horses. J Virol 2013, 87:7185-7190.
31. EMA/CHMP/BWP/814397/2011 Draft guideline on the use of porcine trypsin used in the manufacture of human biological medicinal products, 21 February 2013.
32. Xia H., Vijayaraghavan B., Belák S., Liu L. Detection and identification of the atypical bovine pestiviruses in commercial foetal bovine serum batches. PLoS ONE 2011, 6:e28553.
33. Decaro N., Sciarretta R., Lucente M.S., Mari V., Amorisco F., Colaianni M.L., et al. A nested PCR approach for unambiguous typing of pestiviruses infecting cattle. Mol Cell Probes 2012, 26:42-46.
34. Mckillen J., Mcneilly F., Duffy C., Mcmenamy M., Mcnair I., Hjertner B., et al. Isolation in cell cultures and initial characterisation of two novel bocavirus species from swine in Northern Ireland. Vet Microbiol 2011, 152:39-45.
35. Tischer I., Mields W., Wolff D., Vagt M., Griem W. Studies on epidemiology and pathogenicity of porcine circovirus. Arch Virol 1986, 91:271-276.
36. Allan G.M., Mcneilly F., Kennedy S., Daft B., Clarke E.G., Ellis J.A., et al. Isolation of porcine circovirus-like viruses from pigs with a wasting disease in the USA and Europe. J Vet Diagn Invest 1998, 10:3-10.
37. Wen L., He K., Li B., Wang X., Guo R.L., Yu Z., et al. In vitro and in vivo isolation of a novel rearranged porcine circovirus type 2. J Virol 2012, 86:13120.
38. Wen L., He K., Yu Z., Mao A., Ni Y., Zhang X., et al. Complete genome sequence of a novel porcine circovirus-like agent. J Virol 2012, 86:639.
39. Gilliland S.M., Forrest L., Carre H., Jenkins A., Berry N., Martin J., et al. Investigation of porcine circovirus contamination in human vaccines. Biologicals 2012, 40:270-277.
40. Ma H., Shaheduzzaman S., Willliams D.K., Gao Y., Khan A.S. Investigations of porcine circovirus type 1 (PCV1) in vaccine-related and other cell lines. Vaccine 2011, 29:8429-8437.
41. Nims R.W., Gauvin G., Plavsic M. Gamma irradiation of animal sera for inactivation of viruses and mollicutes - a review. Biologicals 2011, 39:370-377.
42. Prowse C.V. Component pathogen inactivation: a critical review. Vox Sang 2013, 104:183-199.
43. Puvanendiran S., Stone S., Yu W., Johnson C.R., Abrahante J., Jimenez L.G., et al. Absence of porcine circovirus type 1 (PCV1) and high prevalence of PCV 2 exposure and infection in swine finisher herds. Virus Res 2011, 157:92-98.
44. Jones D.T., Taylor W.R., Thornton J.M. The rapid generation of mutation data matrices from protein sequences. Comput Appl Biosci 1992, 8:275-282.
45. Tamura K., Peterson D., Peterson N., Stecher G., Nei M., Kumar S. MEGA5: molecular evolutionary genetics analysis using maximum likelihood, evolutionary distance, and maximum parsimony methods. Mol Biol Evol 2011, 28:2731-2739.